Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04570839
Title COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Compugen Ltd

ovary epithelial cancer

fallopian tube carcinoma

Advanced Solid Tumor

peritoneal carcinoma

endometrial cancer


BMS-986207 + COM701 + Nivolumab


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.